Co-Authors
This is a "connection" page, showing publications co-authored by Julia Tree and Karen Buttigieg.
Connection Strength
0.686
-
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations. Br J Pharmacol. 2021 02; 178(3):626-635.
Score: 0.230
-
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Nat Struct Mol Biol. 2021 Mar; 28(3):326.
Score: 0.058
-
Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19. Nat Commun. 2021 02 24; 12(1):1260.
Score: 0.058
-
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses. Nat Commun. 2021 01 22; 12(1):542.
Score: 0.058
-
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity. Nat Commun. 2021 01 04; 12(1):81.
Score: 0.058
-
Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Nat Struct Mol Biol. 2020 Nov; 27(11):1094.
Score: 0.057
-
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction. Nat Commun. 2020 08 21; 11(1):4198.
Score: 0.056
-
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nat Struct Mol Biol. 2020 10; 27(10):950-958.
Score: 0.056
-
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Nat Struct Mol Biol. 2020 09; 27(9):846-854.
Score: 0.056